Activecare DVT® for the prevention of deep vein thrombosis
Sullivan T, Hiller JE
Record ID 32007000183
English
Authors' results and conclusions:
Given the burden of disease associated with pulmonary embolism (PE) and deep vein thrombosis (DVT) in Australian hospitals, new prophylactic techniques capable of reducing the incidence of these conditions may offer large health benefits. The ActiveCare DVT holds promise as a relatively cheap and effective tool for preventing DVT and PE in high risk patients. At this stage however effectiveness data are limited with only a handful of small scale studies being completed. It is also unclear what the cost impact of the technology will be in Australia.
Authors' recommendations:
Although Activecare DVT provides advantages in portability, it provides similar clinical benefits to patients already provided for by other DVT preventative measures. It is likely that there will be uptake of Activecare DVT into Australian health care system. However, HealthPACT has recommended that further assessment of this technology is no longer warranted.
Details
Project Status:
Completed
Year Published:
2007
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Intermittent Pneumatic Compression Devices
- Regional Blood Flow
- Leg
- Venous Thrombosis
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.